Comprehensive Diabetes Management for Diabetes
(IDEA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this randomized trial is to determine the optimal combination and sequence of three enhancements for a team-based care model for patients living with diabetes in Chicago. The study aim is to determine optimization of intervention components. Participants will be randomly assigned to diabetes self-management training or remote glucose monitoring. After 6 months, participants will be rerandomized to a subsequent study arm (including a CHW support program) depending on a tailoring variable of change in A1c. Researchers will compare the final 6 study arms to see which combination and sequence of enhancements produces the most improvement in A1c.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is the Comprehensive Diabetes Management treatment safe for humans?
How is the Comprehensive Diabetes Management treatment different from other diabetes treatments?
What data supports the effectiveness of this treatment for diabetes management?
Research shows that programs led by community health workers (CHWs) for diabetes self-management education (DSME) help improve blood sugar control and other health outcomes. These programs empower people with diabetes to make better self-care choices and work effectively with healthcare providers.12789
Are You a Good Fit for This Trial?
This trial is for African American/Black or Latinx adults with Type 1 or Type 2 diabetes, an HbA1c level over 7%, and access to a smartphone. They must be current patients who've completed at least one Center appointment and not already using remote glucose monitoring or working with a community health worker.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants are randomized to either Remote Glucose Monitoring or Diabetes Self-Management Training for the first 6 months
Rerandomization and Subsequent Treatment
Participants are rerandomized based on A1c response to continue with or switch to different interventions, including potential addition of Community Health Worker support
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Community Health Worker tailored support
- Diabetes Self-Management Training (DSMT)
- Remote Glucose Monitoring (RGM)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sinai Health System
Lead Sponsor